2024-11-04 14:44:04,708 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:04,709 - INFO - Run 0:
Let me carefully analyze this step-by-step:

Key Observations:
1. Current CDC risk assessment is "Very Low" for general population
2. Specific timeframe: Between August 15, 2024 and September 30, 2024
3. Need to evaluate likelihood of risk assessment changing

Evidence Supporting Potential Risk Increase:
- Africa CDC declared public health emergency of continental security
- WHO declared global public health emergency 
- New mpox variant (clade 1b) detected with higher transmission/severity
- Over 14,000 cases and 500+ deaths in Africa in 2024
- Spread to multiple neighboring countries

Evidence Supporting Continued "Very Low" Risk:
- CDC explicitly states risk to US general population is "Very Low"
- No direct flights from most affected regions
- Limited US case reporting
- Vaccination and previous immunity provide protection
- CDC reviews risk assessment every two weeks

Probability Calculation Considerations:
- Base rate of risk level changes: Low
- Distinctive features of current outbreak: Moderate concern
- Time remaining before resolution: 1.5 months
- Potential for rapid assessment changes: Moderate

Balancing Opposing Risks:
- Risk of overreacting: High
- Risk of underreacting: Moderate

Forecast Reasoning:
While there are concerning developments, the systematic barriers to US transmission remain strong. The CDC has been consistently cautious and precise in its risk assessments.

My Prediction: Between 5.00% and 15.00%, but 10.50% being the most likely. Probability: 10.50%.

2024-11-04 14:44:11,924 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:11,924 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:11,925 - INFO - Run 1:
Let me carefully analyze this step-by-step:

Key Observations:
1. The resolution criteria require a CDC document showing risk level exceeding "Very Low" between Aug 15-Sep 30, 2024
2. Current CDC document (Aug 14, 2024) assesses risk as "VERY LOW"
3. Several key developments have occurred:
- WHO declared global public health emergency for mpox
- Africa CDC declared continental public health emergency
- New clade 1b variant is more transmissible and deadly
- Some increased international concern, but US risk still assessed as low

Forecasting Considerations:
- Base rate: Historically unlikely for CDC to rapidly change risk assessment
- Counterpoint: Significant new information about mpox variant
- Decisive factor: Will new variant evidence trigger risk level change?

Evidence Weighing:
- Current CDC document explicitly states "VERY LOW" risk
- CDC notes will review every two weeks
- Significant new outbreak information exists
- But no direct indication of imminent risk level change

Probability Calculation:
- Low base probability of risk level change
- Moderate probability given new variant information
- Conservative estimate needed

Forecast Rationale:
- Unlikely but not impossible CDC changes risk assessment
- Probability should reflect both current assessment and potential for change

My Prediction: Between 5.00% and 15.00%, but 10.50% being the most likely. Probability: 10.50%.

2024-11-04 14:44:11,925 - INFO - Run 1:
Let me carefully analyze this step-by-step:

Key Observations:
1. The resolution criteria require a CDC document showing risk level exceeding "Very Low" between Aug 15-Sep 30, 2024
2. Current CDC document (Aug 14, 2024) assesses risk as "VERY LOW"
3. Several key developments have occurred:
- WHO declared global public health emergency for mpox
- Africa CDC declared continental public health emergency
- New clade 1b variant is more transmissible and deadly
- Some increased international concern, but US risk still assessed as low

Forecasting Considerations:
- Base rate: Historically unlikely for CDC to rapidly change risk assessment
- Counterpoint: Significant new information about mpox variant
- Decisive factor: Will new variant evidence trigger risk level change?

Evidence Weighing:
- Current CDC document explicitly states "VERY LOW" risk
- CDC notes will review every two weeks
- Significant new outbreak information exists
- But no direct indication of imminent risk level change

Probability Calculation:
- Low base probability of risk level change
- Moderate probability given new variant information
- Conservative estimate needed

Forecast Rationale:
- Unlikely but not impossible CDC changes risk assessment
- Probability should reflect both current assessment and potential for change

My Prediction: Between 5.00% and 15.00%, but 10.50% being the most likely. Probability: 10.50%.

2024-11-04 14:44:19,751 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:19,751 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:19,751 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:19,752 - INFO - Run 2:
Let me systematically analyze this forecast:

Key Observations:
1. Specific Timeframe: August 15, 2024 - September 30, 2024
2. Current CDC Assessment (August 14, 2024): Risk to general population is VERY LOW
3. New Developments:
- WHO declared global public health emergency
- Africa CDC declared continental public health emergency
- New mpox variant (clade Ib) more transmissible and severe
- Over 14,000 cases in Africa in 2024
- Mortality rates higher than previous outbreaks

Forecast Reasoning:
- Base rate: Historically, CDC risk assessments are conservative
- Current assessment is explicitly "VERY LOW"
- No reported US cases of clade Ib
- CDC notes "very low" risk with "moderate confidence"
- Multiple health agencies (ECDC, WHO) consistently emphasize low risk to general population
- CDC will review evidence every two weeks

Counterarguments for Potential Risk Increase:
- Emerging new variant
- Potential for imported cases
- Declining public awareness about mpox
- Increasing global cases

Probability Calculation:
- Low probability of risk exceeding "Very Low"
- Some uncertainty due to emerging variant
- Conservative estimate needed

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:19,752 - INFO - Run 2:
Let me systematically analyze this forecast:

Key Observations:
1. Specific Timeframe: August 15, 2024 - September 30, 2024
2. Current CDC Assessment (August 14, 2024): Risk to general population is VERY LOW
3. New Developments:
- WHO declared global public health emergency
- Africa CDC declared continental public health emergency
- New mpox variant (clade Ib) more transmissible and severe
- Over 14,000 cases in Africa in 2024
- Mortality rates higher than previous outbreaks

Forecast Reasoning:
- Base rate: Historically, CDC risk assessments are conservative
- Current assessment is explicitly "VERY LOW"
- No reported US cases of clade Ib
- CDC notes "very low" risk with "moderate confidence"
- Multiple health agencies (ECDC, WHO) consistently emphasize low risk to general population
- CDC will review evidence every two weeks

Counterarguments for Potential Risk Increase:
- Emerging new variant
- Potential for imported cases
- Declining public awareness about mpox
- Increasing global cases

Probability Calculation:
- Low probability of risk exceeding "Very Low"
- Some uncertainty due to emerging variant
- Conservative estimate needed

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:19,752 - INFO - Run 2:
Let me systematically analyze this forecast:

Key Observations:
1. Specific Timeframe: August 15, 2024 - September 30, 2024
2. Current CDC Assessment (August 14, 2024): Risk to general population is VERY LOW
3. New Developments:
- WHO declared global public health emergency
- Africa CDC declared continental public health emergency
- New mpox variant (clade Ib) more transmissible and severe
- Over 14,000 cases in Africa in 2024
- Mortality rates higher than previous outbreaks

Forecast Reasoning:
- Base rate: Historically, CDC risk assessments are conservative
- Current assessment is explicitly "VERY LOW"
- No reported US cases of clade Ib
- CDC notes "very low" risk with "moderate confidence"
- Multiple health agencies (ECDC, WHO) consistently emphasize low risk to general population
- CDC will review evidence every two weeks

Counterarguments for Potential Risk Increase:
- Emerging new variant
- Potential for imported cases
- Declining public awareness about mpox
- Increasing global cases

Probability Calculation:
- Low probability of risk exceeding "Very Low"
- Some uncertainty due to emerging variant
- Conservative estimate needed

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:26,961 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:26,961 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:26,961 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:26,961 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:26,962 - INFO - Run 3:
Let me break this down systematically:

Key Evidence Analysis:
1. Current CDC Assessment (Aug 14, 2024 document):
- Overall risk to general population: VERY LOW
- Moderate confidence
- Risk specifically for MSM: LOW to MODERATE

2. WHO Context:
- Declared public health emergency of international concern
- New clade Ib variant more severe
- 14,250 cases, 456 deaths in Africa in 2024
- Spread to multiple African countries

3. Timing Considerations:
- Question period: Aug 15 - Sep 30, 2024
- Multiple health agencies emphasize current risk remains low
- No reported US cases of new variant

4. Risk Transmission Factors:
- Limited international travel
- No direct flights from most affected regions
- Existing vaccination programs
- Previous experience managing outbreaks

Probabilistic Reasoning:
- Base rate of risk escalation: Low
- Potential triggering events: Significant spread, new mutation
- Current evidence suggests containment efforts working

Probability Calculation Rationale:
- Strong institutional monitoring
- Proactive public health responses
- Continued "Very Low" risk more likely than escalation

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:26,962 - INFO - Run 3:
Let me break this down systematically:

Key Evidence Analysis:
1. Current CDC Assessment (Aug 14, 2024 document):
- Overall risk to general population: VERY LOW
- Moderate confidence
- Risk specifically for MSM: LOW to MODERATE

2. WHO Context:
- Declared public health emergency of international concern
- New clade Ib variant more severe
- 14,250 cases, 456 deaths in Africa in 2024
- Spread to multiple African countries

3. Timing Considerations:
- Question period: Aug 15 - Sep 30, 2024
- Multiple health agencies emphasize current risk remains low
- No reported US cases of new variant

4. Risk Transmission Factors:
- Limited international travel
- No direct flights from most affected regions
- Existing vaccination programs
- Previous experience managing outbreaks

Probabilistic Reasoning:
- Base rate of risk escalation: Low
- Potential triggering events: Significant spread, new mutation
- Current evidence suggests containment efforts working

Probability Calculation Rationale:
- Strong institutional monitoring
- Proactive public health responses
- Continued "Very Low" risk more likely than escalation

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:26,962 - INFO - Run 3:
Let me break this down systematically:

Key Evidence Analysis:
1. Current CDC Assessment (Aug 14, 2024 document):
- Overall risk to general population: VERY LOW
- Moderate confidence
- Risk specifically for MSM: LOW to MODERATE

2. WHO Context:
- Declared public health emergency of international concern
- New clade Ib variant more severe
- 14,250 cases, 456 deaths in Africa in 2024
- Spread to multiple African countries

3. Timing Considerations:
- Question period: Aug 15 - Sep 30, 2024
- Multiple health agencies emphasize current risk remains low
- No reported US cases of new variant

4. Risk Transmission Factors:
- Limited international travel
- No direct flights from most affected regions
- Existing vaccination programs
- Previous experience managing outbreaks

Probabilistic Reasoning:
- Base rate of risk escalation: Low
- Potential triggering events: Significant spread, new mutation
- Current evidence suggests containment efforts working

Probability Calculation Rationale:
- Strong institutional monitoring
- Proactive public health responses
- Continued "Very Low" risk more likely than escalation

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:26,962 - INFO - Run 3:
Let me break this down systematically:

Key Evidence Analysis:
1. Current CDC Assessment (Aug 14, 2024 document):
- Overall risk to general population: VERY LOW
- Moderate confidence
- Risk specifically for MSM: LOW to MODERATE

2. WHO Context:
- Declared public health emergency of international concern
- New clade Ib variant more severe
- 14,250 cases, 456 deaths in Africa in 2024
- Spread to multiple African countries

3. Timing Considerations:
- Question period: Aug 15 - Sep 30, 2024
- Multiple health agencies emphasize current risk remains low
- No reported US cases of new variant

4. Risk Transmission Factors:
- Limited international travel
- No direct flights from most affected regions
- Existing vaccination programs
- Previous experience managing outbreaks

Probabilistic Reasoning:
- Base rate of risk escalation: Low
- Potential triggering events: Significant spread, new mutation
- Current evidence suggests containment efforts working

Probability Calculation Rationale:
- Strong institutional monitoring
- Proactive public health responses
- Continued "Very Low" risk more likely than escalation

My Prediction: Between 5.00% and 15.00%, but 8.50% being the most likely. Probability: 8.50%.

2024-11-04 14:44:34,749 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:34,749 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:34,749 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:34,749 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:34,749 - INFO - Question: Will the CDC's assessment of the risk posed by mpox to the US general public exceed "Very Low" before October 1, 2024?
2024-11-04 14:44:34,750 - INFO - Run 4:
Let me carefully analyze this step-by-step:

Key Evidence Analysis:
1. Current CDC Assessment: As of August 14, 2024, CDC explicitly states risk to general US population is "VERY LOW"

2. Temporal Constraints:
- Resolution window: August 15 - September 30, 2024
- Current date: August 23, 2024
- Remaining time: About 5-6 weeks

3. Risk Factors:
- New mpox clade Ib detected in Africa
- Higher transmission and mortality rate
- WHO declared global health emergency
- Spread to multiple African countries

4. Mitigating Factors:
- CDC repeatedly emphasizes very low US risk
- No direct flights from affected regions
- Existing vaccination knowledge
- Limited international transmission so far

5. Trend Assessment:
- No significant indication of risk escalation in US
- Continued monitoring by health authorities
- Proactive global response

Probability Reasoning:
- Base rate of risk elevation: Very low
- Specific circumstances: Slight upward pressure from new variant
- Need for extraordinary circumstances to exceed "Very Low"

Balancing Considerations:
- Prudence suggests keeping probability low
- Recognize potential for unexpected developments
- Avoid over-reacting to international alerts

Probabilistic Estimate:
- Low likelihood of exceeding "Very Low"
- Small but non-zero chance of risk escalation

My Prediction: Between 3.50% and 12.75%, but 7.25% being the most likely. Probability: 7.25%.

2024-11-04 14:44:34,750 - INFO - Run 4:
Let me carefully analyze this step-by-step:

Key Evidence Analysis:
1. Current CDC Assessment: As of August 14, 2024, CDC explicitly states risk to general US population is "VERY LOW"

2. Temporal Constraints:
- Resolution window: August 15 - September 30, 2024
- Current date: August 23, 2024
- Remaining time: About 5-6 weeks

3. Risk Factors:
- New mpox clade Ib detected in Africa
- Higher transmission and mortality rate
- WHO declared global health emergency
- Spread to multiple African countries

4. Mitigating Factors:
- CDC repeatedly emphasizes very low US risk
- No direct flights from affected regions
- Existing vaccination knowledge
- Limited international transmission so far

5. Trend Assessment:
- No significant indication of risk escalation in US
- Continued monitoring by health authorities
- Proactive global response

Probability Reasoning:
- Base rate of risk elevation: Very low
- Specific circumstances: Slight upward pressure from new variant
- Need for extraordinary circumstances to exceed "Very Low"

Balancing Considerations:
- Prudence suggests keeping probability low
- Recognize potential for unexpected developments
- Avoid over-reacting to international alerts

Probabilistic Estimate:
- Low likelihood of exceeding "Very Low"
- Small but non-zero chance of risk escalation

My Prediction: Between 3.50% and 12.75%, but 7.25% being the most likely. Probability: 7.25%.

2024-11-04 14:44:34,750 - INFO - Run 4:
Let me carefully analyze this step-by-step:

Key Evidence Analysis:
1. Current CDC Assessment: As of August 14, 2024, CDC explicitly states risk to general US population is "VERY LOW"

2. Temporal Constraints:
- Resolution window: August 15 - September 30, 2024
- Current date: August 23, 2024
- Remaining time: About 5-6 weeks

3. Risk Factors:
- New mpox clade Ib detected in Africa
- Higher transmission and mortality rate
- WHO declared global health emergency
- Spread to multiple African countries

4. Mitigating Factors:
- CDC repeatedly emphasizes very low US risk
- No direct flights from affected regions
- Existing vaccination knowledge
- Limited international transmission so far

5. Trend Assessment:
- No significant indication of risk escalation in US
- Continued monitoring by health authorities
- Proactive global response

Probability Reasoning:
- Base rate of risk elevation: Very low
- Specific circumstances: Slight upward pressure from new variant
- Need for extraordinary circumstances to exceed "Very Low"

Balancing Considerations:
- Prudence suggests keeping probability low
- Recognize potential for unexpected developments
- Avoid over-reacting to international alerts

Probabilistic Estimate:
- Low likelihood of exceeding "Very Low"
- Small but non-zero chance of risk escalation

My Prediction: Between 3.50% and 12.75%, but 7.25% being the most likely. Probability: 7.25%.

2024-11-04 14:44:34,750 - INFO - Run 4:
Let me carefully analyze this step-by-step:

Key Evidence Analysis:
1. Current CDC Assessment: As of August 14, 2024, CDC explicitly states risk to general US population is "VERY LOW"

2. Temporal Constraints:
- Resolution window: August 15 - September 30, 2024
- Current date: August 23, 2024
- Remaining time: About 5-6 weeks

3. Risk Factors:
- New mpox clade Ib detected in Africa
- Higher transmission and mortality rate
- WHO declared global health emergency
- Spread to multiple African countries

4. Mitigating Factors:
- CDC repeatedly emphasizes very low US risk
- No direct flights from affected regions
- Existing vaccination knowledge
- Limited international transmission so far

5. Trend Assessment:
- No significant indication of risk escalation in US
- Continued monitoring by health authorities
- Proactive global response

Probability Reasoning:
- Base rate of risk elevation: Very low
- Specific circumstances: Slight upward pressure from new variant
- Need for extraordinary circumstances to exceed "Very Low"

Balancing Considerations:
- Prudence suggests keeping probability low
- Recognize potential for unexpected developments
- Avoid over-reacting to international alerts

Probabilistic Estimate:
- Low likelihood of exceeding "Very Low"
- Small but non-zero chance of risk escalation

My Prediction: Between 3.50% and 12.75%, but 7.25% being the most likely. Probability: 7.25%.

2024-11-04 14:44:34,750 - INFO - Run 4:
Let me carefully analyze this step-by-step:

Key Evidence Analysis:
1. Current CDC Assessment: As of August 14, 2024, CDC explicitly states risk to general US population is "VERY LOW"

2. Temporal Constraints:
- Resolution window: August 15 - September 30, 2024
- Current date: August 23, 2024
- Remaining time: About 5-6 weeks

3. Risk Factors:
- New mpox clade Ib detected in Africa
- Higher transmission and mortality rate
- WHO declared global health emergency
- Spread to multiple African countries

4. Mitigating Factors:
- CDC repeatedly emphasizes very low US risk
- No direct flights from affected regions
- Existing vaccination knowledge
- Limited international transmission so far

5. Trend Assessment:
- No significant indication of risk escalation in US
- Continued monitoring by health authorities
- Proactive global response

Probability Reasoning:
- Base rate of risk elevation: Very low
- Specific circumstances: Slight upward pressure from new variant
- Need for extraordinary circumstances to exceed "Very Low"

Balancing Considerations:
- Prudence suggests keeping probability low
- Recognize potential for unexpected developments
- Avoid over-reacting to international alerts

Probabilistic Estimate:
- Low likelihood of exceeding "Very Low"
- Small but non-zero chance of risk escalation

My Prediction: Between 3.50% and 12.75%, but 7.25% being the most likely. Probability: 7.25%.

